Dr. Alsidawi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
375 Dixmyth Ave
Cincinnati, OH 45220Phone+1 513-853-1300Fax+1 513-451-1356
Education & Training
University of Cincinnati Medical Center/College of MedicineResidency, Internal Medicine, 2012 - 2015
Damascus University Faculty of MedicineClass of 2011
Certifications & Licensure
OH State Medical License 2012 - 2025
MN State Medical License 2015 - 2019- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 13 citationsExceptional response to everolimus in a novel tuberous sclerosis complex-2 mutation-associated metastatic renal-cell carcinoma.Samer Alsidawi, Pashtoon Murtaza Kasi
Cold Spring Harbor Molecular Case Studies. 2018-04-02 - 32 citationsThe brain microenvironment negatively regulates miRNA-768-3p to promote K-ras expression and lung cancer metastasisArasukumar Subramani, Samer Alsidawi, Sajjeev Jagannathan, Kazutaka Sumita, Atsuo T. Sasaki
Scientific Reports. 2013-08-09 - 89 citationsExpression of PD-1 and PD-L1 in Anaplastic Thyroid Cancer Patients Treated With Multimodal Therapy: Results From a Retrospective Study.Ashish V. Chintakuntlawar, Kandelaria M. Rumilla, Carin Y. Smith, Sarah M. Jenkins, Robert L. Foote
The Journal of Clinical Endocrinology and Metabolism. 2017-06-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
